Verrica Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CALIGAN PARTNERS LP | 11/14/2025 | 923.91 K | $3.98 M | 100.00% | 9.74% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 639.19 K | $2.75 M | 100.00% | 6.74% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 280.73 K | $1.21 M | 100.00% | 2.96% |
| VANGUARD GROUP INC | 11/07/2025 | 225.21 K | $970.66 K | 100.00% | 2.37% |
| SOVRAN ADVISORS, LLC | 10/31/2025 | 73.81 K | $260.53 K | 100.00% | 0.78% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 71.99 K | $310.28 K | 100.00% | 0.76% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 67.66 K | $291.69 K | 100.00% | 0.71% |
| UBS GROUP AG | 11/13/2025 | 41.63 K | $179.43 K | 100.00% | 0.44% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 29.19 K | $125.81 K | 100.00% | 0.31% |
| MARINER, LLC | 11/14/2025 | 24.55 K | $105.81 K | 100.00% | 0.26% |
| MORGAN STANLEY | 11/14/2025 | 21.69 K | $93.48 K | 100.00% | 0.23% |
| STATE STREET CORP | 11/14/2025 | 20.58 K | $88.70 K | 100.00% | 0.22% |
| NORTHERN TRUST CORP | 11/14/2025 | 20.03 K | $86.33 K | 100.00% | 0.21% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 12.00 K | $51.72 K | 100.00% | 0.13% |
| BLACKROCK, INC. | 11/12/2025 | 6.15 K | $26.50 K | 100.00% | 0.06% |
| FMR LLC | 11/13/2025 | 3.34 K | $14.38 K | 100.00% | 0.04% |
| CITIGROUP INC | 11/10/2025 | 2.07 K | $8.90 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.54 K | $6.65 K | 100.00% | 0.02% |
| CAPITAL ANALYSTS, LLC | 11/14/2025 | 1.50 K | $6.00 K | 100.00% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.21 K | $5.00 K | 100.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 568 | $301 | 0.00% | 0.01% |
| SALOMON & LUDWIN, LLC | 10/21/2025 | 290 | $1.35 K | 100.00% | 0.00% |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 10/22/2025 | 200 | $862 | 100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 142 | $612 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 124 | $534 | 100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 102 | $439 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 72 | $310 | 100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 11/10/2025 | 31 | $134 | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 9 | $38 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 3 | $13 | 100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 2 | $9 | 100.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 1 | $4 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Verrica Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of Verrica Pharmaceuticals Inc.. The most heavily invested institutionals were:
Caligan Partners LP: 923,910
ARMISTICE CAPITAL, LLC: 639,193
BOOTHBAY FUND MANAGEMENT, LLC: 280,734
VANGUARD GROUP INC: 225,210
Sovran Advisors, LLC: 73,805
MILLENNIUM MANAGEMENT LLC: 71,990
26.02% of Verrica Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.73 M shares in the last 24 months. This purchase volume represents approximately $17.40 M in transactions.